003220 — Daewon Pharmaceutical Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩320bn
- KR₩434bn
- KR₩527bn
- 68
- 67
- 46
- 68
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 317,828 | 308,501 | 354,176 | 478,885 | 526,952 |
Cost of Revenue | |||||
Gross Profit | 180,155 | 165,937 | 176,468 | 237,942 | 257,247 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 283,377 | 285,118 | 335,862 | 438,032 | 499,316 |
Operating Profit | 34,451 | 23,383 | 18,314 | 40,853 | 27,636 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 35,372 | 23,642 | 17,136 | 38,722 | 25,830 |
Provision for Income Taxes | |||||
Net Income After Taxes | 26,879 | 17,198 | 6,611 | 30,657 | 23,463 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 27,289 | 17,640 | 6,989 | 31,944 | 23,917 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 27,289 | 17,640 | 6,989 | 31,944 | 23,917 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1,288 | 851 | 363 | 1,589 | 1,332 |
Dividends per Share |